Author: Ken Dropiewski

Pulse Biosciences’ Nanosecond PFA Technology to be Featured in Multiple Presentations at the AF Symposium

anuary 13, 2025 07:00 AM Eastern Standard Time MIAMI–(BUSINESS WIRE)–Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation™ (nsPFA™) technology, today announced that its nsPFA technology will be featured in a late-breaking science session and a live case transmission featuring the nsPFA 360° […]

AngioDynamics Announces Publication of APEX-AV Trial Results in JSCAI

LATHAM, N.Y.–(BUSINESS WIRE)–AngioDynamics, Inc. (NASDAQ: ANGO), a leading and transformative medical technology company focused on restoring healthy blood flow in the body’s vascular system, expanding cancer treatment options and improving patient quality of life, today announced the publication of the results from the Acute Pulmonary Embolism Extraction Trial with the […]

Scientia Vascular Announces Leadership Transition: John Lippert to Assume CTO Role; Rick Randall Appointed as CEO and Chairman

WEST VALLEY CITY, Utah, Jan. 13, 2025 /PRNewswire/ — Scientia Vascular, a leading innovator in neurovascular medical devices, announces a strategic leadership transition to further drive innovation and growth. Founder and Chief Executive Officer (CEO) John Lippert will transition to the…

BRAIN.Q Achieves CE Mark for Its Breakthrough Therapy for Reducing Disability Following Stroke and Welcomes Stacey Pugh as Chairman of the Board

ENGLEWOOD CLIFFS, N.J., Jan. 13, 2025 /PRNewswire/ — BRAIN.Q, is excited to announce the CE Mark for its BQ 2.0 system, designed to reduce disability following ischemic stroke, the number one cause of disability worldwide. Reducing stroke disability is often achieved through endovascular…